Vol 2, No 1-2 (2019)
- Year: 2019
- Published: 07.03.2019
- Articles: 5
- URL: https://oncopathology.abvpress.ru/2618-7019/issue/view/14609
Full Issue
Reviews and lectures
Pharmacogenetic testing for individualization of hormonal therapy with tamoxifen
Abstract
Tamoxifen is a drug of choice for endocrine therapy of hormone receptor-positive breast cancer in women of the reproductive period. The metabolic activity of tamoxifen is determined by the activity of the enzyme CYP2D6, encoded by the gene of the same name: under the action of the enzyme, tamoxifen passes into the metabolically active form, endoxyphene. Pharmacogenetic testing of the CYP2D6 gene in patients with hormone-positive breast cancer can help predict the effectiveness of therapy and assess the risk of side effects with the aim of improving long-term treatment outcomes.
Oncopathology. 2019;2(1-2):10-21
10-21
Ectopic pancreas: literature review and case report of neuroendocrine carcinoma of the major duodenal papilla originating from ectopic pancreatic tissue
Abstract
We report a case of small-cell neuroendocrine carcinoma of the major duodenal papilla in a 62-year-old female patient with mechanical jaundice developed from the heterotopic pancreatic tissue with a transitional area from ectopic tissue to the tumor. This article also reviews the literature on pancreatic ectopic tissue in various organs and tumors developing from this tissue. Most commonly, an ectopic pancreas is seen in the stomach (24-38 %); less common locations include the duodenum/major duodenal papilla (9-36 %) and jejunum (0.5-27.0 %). Rarely, pancreatic ectopic tissue can be found in the colon, Meckel’s diverticulum, umbilical region, liver, gallbladder, intestinal mesenteries, rectum, and pelvic organs. Current literature describes various types of tumors originating from ectopic pancreatic tissue, including mixed tumors (carcinoid plus signet ring cell gastric carcinoma, intraductal papillary mucinous tumor plus adenocarcinoma, and adenocarcinoma plus acinar cell tumor), adenocarcinomas, solid pseudopapillary tumors, anaplastic carcinomas, and neuroendocrine tumors.
Oncopathology. 2019;2(1-2):22-30
22-30
Original reports
The cytologic diagnostics of meningiomas in the neurosurgical hosp
Abstract
Work is executed for the purpose of definition of ways of optimisation of pathoanatomical diagnosis in a neurosurgical hospital. Results of special research of398 intraoperational urgent biopsies of meningiomas of central nervous system are generalised, the cytologic criteria of morphological diagnostics of various histological variants of meningiomas are described. Application of the cytologic method in research urgent intraoperational biopsies at neurosurgical patients is proved.
Oncopathology. 2019;2(1-2):31-46
31-46
Methodical materials and practical recommendations
Standardization of result reporting in pathomorphological examination of prostate biopsy specimens
Abstract
Prostate cancer (PCa) is one of the most common malignancies in middle-aged and elderly men. We observe a trend toward increasing incidence of PCa in the USA, Europe, and Russia. Treatment of PCa patients is largely based on the results of transrectal multifocal prostate biopsy, which is considered to be the gold standard for PCa diagnostics. Therefore, there is a clear need for standardization of the result reporting system used in pathomorphological examination of prostate biopsy specimens. This article describes the principles of tumor grading, processing of biopsy samples, and the requirements for standard pathomorphological reports.
Oncopathology. 2019;2(1-2):47-51
47-51
The draft of references on cytomorphological diagnosis of the urinary tract pathology
Abstract
A draft of recommendations on cytomorphological diagnosis of the urinary tract pathology is presented. The paper highlights the main points of the pre-analytical stage: the obtaining of the material, its preparation and staining. The categories of the Paris System are presented, the main cytomorphological criteria for assessing the urinary pathology in cytopreparations are noted.
Oncopathology. 2019;2(1-2):52-67
52-67
